Polymorphs and cocrystals of nalidixic acid
Polymorphs and cocrystals of nalidixic acid
| dc.contributor.author | Gangavaram, Swarupa | |
| dc.contributor.author | Raghavender, S. | |
| dc.contributor.author | Sanphui, Palash | |
| dc.contributor.author | Pal, Sharmistha | |
| dc.contributor.author | Manjunatha, Sulur G. | |
| dc.contributor.author | Nambiar, Sudhir | |
| dc.contributor.author | Nangia, Ashwini | |
| dc.date.accessioned | 2022-03-27T09:26:32Z | |
| dc.date.available | 2022-03-27T09:26:32Z | |
| dc.date.issued | 2012-10-03 | |
| dc.description.abstract | Only one X-ray crystal structure of the parent quinolone antibiotic nalidixic acid is known in the published and patent literature. A systematic search for new solid-state forms of the drug yielded two polymorphs (forms II and III) and six cocrystals with resorcinol, catechol, hydroquinone, pyrogallol, orcinol, and phloroglucinol. Of these, X-ray crystal structures were determined for polymorph II and cocrystals with resorcinol, catechol, hydroquinone, and pyrogallol, whereas the remaining solid forms were identified by their unique powder X-ray diffraction patterns. Nalidixic acid is intramolecularly O-H⋯O hydrogen bonded in a six-member ring, and its molecular dimers are assembled via C-H⋯O synthon. The OH donors on phenolic coformers H bond with the α-keto acid moiety of the drug as connectors and spacers. Intermolecular drug-drug C-H⋯O interactions in polymorphs are replaced by strong drug-coformer O-H⋯O hydrogen bonds in cocrystals. © 2012 American Chemical Society. | |
| dc.identifier.citation | Crystal Growth and Design. v.12(10) | |
| dc.identifier.issn | 15287483 | |
| dc.identifier.uri | 10.1021/cg300895c | |
| dc.identifier.uri | https://pubs.acs.org/doi/10.1021/cg300895c | |
| dc.identifier.uri | https://dspace.uohyd.ac.in/handle/1/12909 | |
| dc.title | Polymorphs and cocrystals of nalidixic acid | |
| dc.type | Journal. Article | |
| dspace.entity.type |
Files
License bundle
1 - 1 of 1